Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
May 3, 2021European Journal of Gastroenterology & Hepatology

Evaluating the conversion to extended-release tacrolimus from immediate-release tacrolimus in liver transplant recipients

View Full Paper
Ask AI
Bookmark
Share

Authors

DCDavid ChoiUniversity of ChicagoSTSarang ThakerNorthwestern UniversityPWPatricia West‐ThielkeUniversity of Illinois Chicago

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Choi et al. (2021) studied this question.

synapsesocial.com/papers/6ab49ce5f63ee7f7a5fd7280https://doi.org/10.1097/meg.0000000000002172
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Pharmacokinetics for Once- Versus Twice-Daily Tacrolimus Formulations in De Novo Kidney Transplantation: A Randomized, Open-Label Trial2009 · 128 citations
  2. 2Comparison of the long-term efficacy and safety of generic tacrolimus, Tacrobell, with Prograf in liver transplant recipients2018 · 6 citations
  3. 3A Low Tacrolimus Concentration/Dose Ratio Increases the Risk for the Development of Acute Calcineurin Inhibitor-Induced Nephrotoxicity2019 · 63 citations
  4. 4Switching ST udy of Kidney TRansplant PA tients with Tremor to LCP ‐TacrO ( STRATO ): an open‐label, multicenter, prospective phase 3b study2015 · 120 citations